Roger Pomerantz

Roger Pomerantz

Chairman chez VIRACTA THERAPEUTICS, INC.

Fortune : 101 363 $ au 31/03/2024

67 ans
Health Technology
Consumer Services
Commercial Services

Profil

Roger James Pomerantz is currently the Chairman at CollPlant Biotechnologies Ltd., Silicon INSITE, Inc., Viracta Subsidiary, Inc., and Indaptus Therapeutics, Inc. He is also the Vice Chairman at Enlivex Therapeutics Ltd.
Additionally, he holds positions as a Director at Silicon Therapeutics, Inc., X-Vax Technology, Inc., and Verimmune, Inc. Furthermore, he is an Independent Director at Aprinoia Therapeutics, Inc. and the President of Pomerantz Life Sciences Consulting Group LLC.
In his former roles, Dr. Pomerantz served as the President & Chief Executive Officer of Tibotec Pharmaceuticals and as the Chairman of Sunesis Pharmaceuticals, Inc. He was also the Chairman of the Institute of Human Virology from 2002 to 2005.
Additionally, he held the position of Chairman at ContraFect Corp.
in 2023, Seres Therapeutics, Inc. in 2019, and Rubius Therapeutics, Inc. from 2014 to 2019.
He was the Senior VP & Head-Licensing & Acquisitions at Merck & Co., Inc. from 2011 to 2013.
Moreover, he served as the President of Janssen R&D Ireland Ltd.
from 2005 to 2010 and as the Global Head-Infectious Diseases at Johnson & Johnson Pharmaceutical Group from 2005 to 2010.
Dr. Pomerantz's education includes an undergraduate degree from The Johns Hopkins University and a doctorate from The Johns Hopkins University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
25/02/2024 99 375 ( 0,25% ) 101 363 $ 31/03/2024
06/09/2023 1 ( 0,00% ) 0 $ 31/03/2024
25/05/2023 0 ( -.--% ) - $ 31/03/2024
20/03/2024 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Roger Pomerantz

SociétésPosteDébut
COLLPLANT BIOTECHNOLOGIES LTD. Chairman 10/02/2020
VIRACTA THERAPEUTICS, INC. Chairman 01/09/2020
INDAPTUS THERAPEUTICS, INC. Chairman 01/08/2021
ENLIVEX THERAPEUTICS LTD. Director/Board Member 23/05/2022
Chairman 14/09/2020
Chairman 08/07/2019
Pomerantz Life Sciences Consulting Group LLC President -
Director/Board Member -
Tous les postes actifs de Roger Pomerantz

Anciens postes connus de Roger Pomerantz

SociétésPosteFin
CONTRAFECT CORPORATION Chief Executive Officer 15/11/2023
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Roger Pomerantz

Formation de Roger Pomerantz

The Johns Hopkins University Undergraduate Degree
The Johns Hopkins University School of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Roger Pomerantz

Relations

100 +

Relations au 1er degré

28

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées8
MERCK & CO., INC.

Health Technology

MOLECULAR PHARMACOLOGY (USA), LTD.

Commercial Services

CONTRAFECT CORPORATION

Health Technology

COLLPLANT BIOTECHNOLOGIES LTD.

Health Technology

SERES THERAPEUTICS, INC.

Health Technology

EVELO BIOSCIENCES, INC.

Health Technology

ENLIVEX THERAPEUTICS LTD.

Health Technology

VIRACTA THERAPEUTICS, INC.

Health Technology

Entreprise privées16

Health Technology

Janssen R&D Ireland Ltd.

Health Services

Finance

Consumer Services

Johnson & Johnson Pharmaceutical Group

Tibotec Pharmaceuticals

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Janssen Therapeutics, Inc.

Pomerantz Life Sciences Consulting Group LLC

Indaptus Therapeutics, Inc.

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Roger Pomerantz